{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T21:11:09Z","timestamp":1794517869708,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":215,"publisher":"Springer New York","isbn-type":[{"value":"9781493936267","type":"print"},{"value":"9781493936281","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3628-1_1","type":"book-chapter","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T06:34:31Z","timestamp":1463121271000},"page":"3-33","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Assessing Tumor Angiogenesis in Histological Samples"],"prefix":"10.1007","author":[{"given":"Jia-Min","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Jene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,13]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1056\/NEJM197108122850711","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J (1971) Tumour angiogenesis: therapeutic implications. N Engl J Med 285:82\u201386","journal-title":"N Engl J Med"},{"key":"1_CR2","first-page":"347","volume":"48","author":"S Brem","year":"1972","unstructured":"Brem S, Cotran R, Folkman J (1972) Tumor angiogenesis: a quantitative method for histological grading. J Natl Cancer Inst 48:347\u2013356","journal-title":"J Natl Cancer Inst"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/bjc.1985.282","volume":"52","author":"M Mlynek","year":"1985","unstructured":"Mlynek M, van Beunigen D, Leder L-D, Streffer C (1985) Measurement of the grade of vascularisation in histological tumour tissue sections. Br J Cancer 52:945\u2013948","journal-title":"Br J Cancer"},{"key":"1_CR4","first-page":"419","volume":"133","author":"A Svrivastava","year":"1988","unstructured":"Svrivastava A, Laidler P, Davies R, Horgan K, Hughes L (1988) The prognostic significance of tumor vascularity in intermediate-thickness (0.76\u20134.0 mm thick) skin melanoma. Am J Pathol 133:419\u2013423","journal-title":"Am J Pathol"},{"issue":"2","key":"1_CR5","first-page":"587","volume":"54","author":"R Porschen","year":"1994","unstructured":"Porschen R, Classen S, Piontek M, Borchard F (1994) Vascularization of carcinomas of the esophagus and its correlation with tumor proliferation. Cancer Res 54(2):587\u2013591","journal-title":"Cancer Res"},{"issue":"1","key":"1_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199101033240101","volume":"324","author":"N Weidner","year":"1991","unstructured":"Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis\u2014correlation in invasive breast carcinoma. N Engl J Med 324(1):1\u20138","journal-title":"N Engl J Med"},{"issue":"3","key":"1_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1046\/j.1365-2559.1997.d01-606.x","volume":"30","author":"SB Fox","year":"1997","unstructured":"Fox SB (1997) Tumour angiogenesis and prognosis. Histopathology 30(3):294\u2013301","journal-title":"Histopathology"},{"key":"1_CR8","first-page":"441","volume-title":"Diseases of the breast","author":"S Fox","year":"2004","unstructured":"Fox S, Harris A (2004) The biology of breast tumor angiogenesis. In: Harris J, Lippman ME, Morrow M, Osborne CK (eds) Diseases of the breast, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 441\u2013458","edition":"3"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","volume":"82","author":"J Folkman","year":"1990","unstructured":"Folkman J (1990) What is the evidence that tumours are angiogenesis dependent. J Natl Cancer Inst 82:4\u20136","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"1_CR10","first-page":"1417","volume":"151","author":"F Pezzella","year":"1996","unstructured":"Pezzella F, Pastorin OU, Tagliabue E, Andreola S, Sozzi G, Gasparini G, Menard S, Gatter K, Harris A, Fox S et al (1996) Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 151(5):1417\u20131423","journal-title":"Am J Pathol"},{"issue":"9217","key":"1_CR11","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/S0140-6736(00)02268-6","volume":"355","author":"F Pezzella","year":"2000","unstructured":"Pezzella F (2000) Evidence for novel non-angiogenic pathway in breast-cancer metastasis. Breast Cancer Progression Working Party. Lancet 355(9217):1787\u20131788","journal-title":"Lancet"},{"issue":"5422","key":"1_CR12","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","volume":"284","author":"J Holash","year":"1999","unstructured":"Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284(5422):1994\u20131998","journal-title":"Science"},{"issue":"38","key":"1_CR13","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1038\/sj.onc.1203035","volume":"18","author":"J Holash","year":"1999","unstructured":"Holash J, Wiegand SJ, Yancopoulos GD (1999) New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18(38):5356\u20135362","journal-title":"Oncogene"},{"issue":"3","key":"1_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/path.966","volume":"195","author":"PB Vermeulen","year":"2001","unstructured":"Vermeulen PB, Colpaert C, Salgado R, Royers R, Hellemans H, Van Den Heuvel E, Goovaerts G, Dirix LY, Van Marck E (2001) Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol 195(3):336\u2013342","journal-title":"J Pathol"},{"issue":"6","key":"1_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/ijc.10423","volume":"99","author":"K Shirakawa","year":"2002","unstructured":"Shirakawa K, Wakasugi H, Heike Y, Watanabe I, Yamada S, Saito K, Konishi F (2002) Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer 99(6):821\u2013828","journal-title":"Int J Cancer"},{"issue":"3","key":"1_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1161\/01.RES.85.3.221","volume":"85","author":"T Asahara","year":"1999","unstructured":"Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85(3):221\u2013228","journal-title":"Circ Res"},{"issue":"9216","key":"1_CR17","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/S0140-6736(00)02241-8","volume":"355","author":"E Gunsilius","year":"2000","unstructured":"Gunsilius E, Duba HC, Petzer AL, Kahler CM, Grunewald K, Stockhammer G, Gabl C, Dirnhofer S, Clausen J, Gastl G (2000) Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 355(9216):1688\u20131691","journal-title":"Lancet"},{"issue":"1","key":"1_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1172\/JCI8774","volume":"105","author":"S Rafii","year":"2000","unstructured":"Rafii S (2000) Circulating endothelial precursors: mystery, reality, and promise [comment]. J Clin Invest 105(1):17\u201319","journal-title":"J Clin Invest"},{"issue":"14","key":"1_CR19","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1093\/emboj\/18.14.3964","volume":"18","author":"T Asahara","year":"1999","unstructured":"Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18(14):3964\u20133972","journal-title":"EMBO J"},{"issue":"11","key":"1_CR20","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/nm1101-1194","volume":"7","author":"D Lyden","year":"2001","unstructured":"Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L et al (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7(11):1194\u20131201","journal-title":"Nat Med"},{"issue":"2","key":"1_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1006\/mvre.1996.0025","volume":"51","author":"S Patan","year":"1996","unstructured":"Patan S, Munn LL, Jain RK (1996) Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. Microvasc Res 51(2):260\u2013272","journal-title":"Microvasc Res"},{"issue":"1\u20132","key":"1_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1006493130855","volume":"50","author":"S Patan","year":"2000","unstructured":"Patan S (2000) Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J Neurooncol 50(1\u20132):1\u201315","journal-title":"J Neurooncol"},{"key":"1_CR23","first-page":"9161","volume":"53","author":"S Fox","year":"1993","unstructured":"Fox S, Gatter K, Bicknell R, Going J, Stanton P, Cooke T, Harris A (1993) Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res 53:9161\u20139163","journal-title":"Cancer Res"},{"issue":"21","key":"1_CR24","first-page":"5602","volume":"59","author":"S Kakolyris","year":"1999","unstructured":"Kakolyris S, Giatromanolaki A, Koukourakis M, Leigh IM, Georgoulias V, Kanavaros P, Sivridis E, Gatter KC, Harris AL (1999) Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression. Cancer Res 59(21):5602\u20135607","journal-title":"Cancer Res"},{"issue":"4","key":"1_CR25","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1054\/bjoc.1999.1010","volume":"82","author":"S Kakolyris","year":"2000","unstructured":"Kakolyris S, Fox SB, Koukourakis M, Giatromanolaki A, Brown N, Leek RD, Taylor M, Leigh IM, Gatter KC, Harris AL (2000) Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39. Br J Cancer 82(4):844\u2013851","journal-title":"Br J Cancer"},{"issue":"4","key":"1_CR26","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0002-9440(10)64079-5","volume":"158","author":"AK Sood","year":"2001","unstructured":"Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE, Seftor RE, Hendrix MJ (2001) Molecular determinants of ovarian cancer plasticity. Am J Pathol 158(4):1279\u20131288","journal-title":"Am J Pathol"},{"issue":"18","key":"1_CR27","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1016\/j.ejca.2013.07.148","volume":"49","author":"Z Cao","year":"2013","unstructured":"Cao Z, Bao M, Miele L, Sarkar FH, Wang Z, Zhou Q (2013) Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis. Eur J Cancer 49(18):3914\u20133923","journal-title":"Eur J Cancer"},{"issue":"2","key":"1_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0002-9440(10)64739-6","volume":"156","author":"R Folberg","year":"2000","unstructured":"Folberg R, Hendrix MJ, Maniotis AJ (2000) Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156(2):361\u2013381","journal-title":"Am J Pathol"},{"issue":"2","key":"1_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0002-9440(10)64740-2","volume":"156","author":"DM McDonald","year":"2000","unstructured":"McDonald DM, Munn L, Jain RK (2000) Vasculogenic mimicry: how convincing, how novel, and how significant? Am J Pathol 156(2):383\u2013388","journal-title":"Am J Pathol"},{"key":"1_CR30","first-page":"1","volume-title":"Tumor blood circulation","author":"B Warren","year":"1979","unstructured":"Warren B (1979) The vascular morphology of tumors. In: Peterson H (ed) Tumor blood circulation. CRC Press, Boca Raton, FL, pp 1\u201347"},{"issue":"26","key":"1_CR31","doi-asserted-by":"publisher","first-page":"14608","DOI":"10.1073\/pnas.97.26.14608","volume":"97","author":"YS Chang","year":"2000","unstructured":"Chang YS, di Tomaso E, McDonald DM, Jones R, Jain RK, Munn LL (2000) Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A 97(26):14608\u201314613","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1_CR32","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/S0959-8049(02)00094-1","volume":"38","author":"PB Vermeulen","year":"2002","unstructured":"Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Belien JA, de Waal RM, Van Marck E, Magnani E et al (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38(12):1564\u20131579","journal-title":"Eur J Cancer"},{"issue":"2","key":"1_CR33","first-page":"75","volume":"3","author":"M Barbareschi","year":"1995","unstructured":"Barbareschi M, Weidner N, Gasparini G, Morelli L, Forti S, Eccher C, Fina P, Caffo O, Leonardi E, Mauri F et al (1995) Microvessel quantitation in breast carcinomas. Appl Immunochem 3(2):75\u201384","journal-title":"Appl Immunochem"},{"key":"1_CR34","first-page":"47","volume":"4","author":"H Chalkley","year":"1943","unstructured":"Chalkley H (1943) Method for the quantitative morphological analysis of tissues. J Natl Cancer Inst 4:47\u201353","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"1_CR35","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1093\/jnci\/84.24.1875","volume":"84","author":"N Weidner","year":"1992","unstructured":"Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84(24):1875\u20131887","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"1_CR36","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1093\/jnci\/89.14.1044","volume":"89","author":"SB Fox","year":"1997","unstructured":"Fox SB, Leek RD, Bliss J, Mansi JL, Gusterson B, Gatter KC, Harris AL (1997) Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients. J Natl Cancer Inst 89(14):1044\u20131049","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0163-7258(94)90037-X","volume":"64","author":"FJ Burrows","year":"1994","unstructured":"Burrows FJ, Thorpe PE (1994) Vascular targeting\u2014a new approach to the therapy of solid tumors. Pharmacol Ther 64(1):155\u2013174","journal-title":"Pharmacol Ther"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1023\/A:1005714527315","volume":"15","author":"S Fox","year":"1997","unstructured":"Fox S, Harris A (1997) Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy. Invest New Drugs 15:15\u201328","journal-title":"Invest New Drugs"},{"issue":"5","key":"1_CR39","first-page":"1197","volume":"24","author":"JP Dales","year":"2004","unstructured":"Dales JP, Garcia S, Andrac L, Carpentier S, Ramuz O, Lavaut MN, Allasia C, Bonnier P, Charpin C (2004) Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome. Int J Oncol 24(5):1197\u20131204","journal-title":"Int J Oncol"},{"issue":"3","key":"1_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1440-1789.2005.00632.x","volume":"25","author":"Y Yao","year":"2005","unstructured":"Yao Y, Kubota T, Takeuchi H, Sato K (2005) Prognostic significance of microvessel density determined by an anti-CD105\/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody. Neuropathology 25(3):201\u2013206","journal-title":"Neuropathology"},{"issue":"6","key":"1_CR41","first-page":"2283","volume":"31","author":"F Nassiri","year":"2011","unstructured":"Nassiri F, Cusimano MD, Scheithauer BW, Rotondo F, Fazio A, Yousef GM, Syro LV, Kovacs K, Lloyd RV (2011) Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res 31(6):2283\u20132290","journal-title":"Anticancer Res"},{"issue":"5","key":"1_CR42","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00428-013-1463-8","volume":"463","author":"Y Miyata","year":"2013","unstructured":"Miyata Y, Sagara Y, Watanabe S, Asai A, Matsuo T, Ohba K, Hayashi T, Sakai H (2013) CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34. Virchows Arch 463(5):673\u2013679","journal-title":"Virchows Arch"},{"issue":"12","key":"1_CR43","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1440-1827.2006.02037.x","volume":"56","author":"R Minhajat","year":"2006","unstructured":"Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, Tokunaga O (2006) Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Pathol Int 56(12):717\u2013723","journal-title":"Pathol Int"},{"issue":"1","key":"1_CR44","first-page":"41","volume":"38","author":"G Sica","year":"2011","unstructured":"Sica G, Lama G, Anile C, Geloso MC, La Torre G, De Bonis P, Maira G, Lauriola L, Jhanwar-Uniyal M, Mangiola A (2011) Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma. Int J Oncol 38(1):41\u201349","journal-title":"Int J Oncol"},{"issue":"7","key":"1_CR45","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1038\/bjc.2014.71","volume":"110","author":"A Saroufim","year":"2014","unstructured":"Saroufim A, Messai Y, Hasmim M, Rioux N, Iacovelli R, Verhoest G, Bensalah K, Patard JJ, Albiges L, Azzarone B et al (2014) Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma. Br J Cancer 110(7):1778\u20131784","journal-title":"Br J Cancer"},{"issue":"2","key":"1_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11912-013-0365-x","volume":"16","author":"LS Rosen","year":"2014","unstructured":"Rosen LS, Gordon MS, Robert F, Matei DE (2014) Endoglin for targeted cancer treatment. Curr Oncol Rep 16(2):365","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"1_CR47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3748\/wjg.v19.i1.42","volume":"19","author":"Y Matsuda","year":"2013","unstructured":"Matsuda Y, Hagio M, Ishiwata T (2013) Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis. World J Gastroenterol 19(1):42\u201348","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1_CR48","first-page":"593","volume":"30","author":"N Teranishi","year":"2007","unstructured":"Teranishi N, Naito Z, Ishiwata T, Tanaka N, Furukawa K, Seya T, Shinji S, Tajiri T (2007) Identification of neovasculature using nestin in colorectal cancer. Int J Oncol 30(3):593\u2013603","journal-title":"Int J Oncol"},{"issue":"4","key":"1_CR49","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3748\/wjg.v17.i4.409","volume":"17","author":"T Ishiwata","year":"2011","unstructured":"Ishiwata T, Matsuda Y, Naito Z (2011) Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis. World J Gastroenterol 17(4):409\u2013418","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1_CR50","first-page":"1345","volume":"40","author":"K Yamahatsu","year":"2012","unstructured":"Yamahatsu K, Matsuda Y, Ishiwata T, Uchida E, Naito Z (2012) Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis. Int J Oncol 40(5):1345\u20131357","journal-title":"Int J Oncol"},{"issue":"3","key":"1_CR51","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.breast.2012.07.008","volume":"22","author":"K Kruger","year":"2013","unstructured":"Kruger K, Stefansson IM, Collett K, Arnes JB, Aas T, Akslen LA (2013) Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer. Breast 22(3):282\u2013288","journal-title":"Breast"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S0344-0338(89)80230-4","volume":"185","author":"J Smolle","year":"1989","unstructured":"Smolle J, Soyer HP, Hofmann-Wellenhof R, Smolle-Juettner FM, Kerl H (1989) Vascular architecture of melanocytic skin tumors. Pathol Res Pract 185:740\u2013745","journal-title":"Pathol Res Pract"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00000372-199402000-00003","volume":"16","author":"CJ Cockerell","year":"1994","unstructured":"Cockerell CJ, Sonnier G, Kelly L, Patel S (1994) Comparative analysis of neovascularisation in primary cutaneous melanoma and Spitz nevus. Am J Dermatopathol 16:9\u201313","journal-title":"Am J Dermatopathol"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0161-6420(93)31470-3","volume":"100","author":"R Folberg","year":"1993","unstructured":"Folberg R, Rummelt V, Ginderdeuren R-V, Hwang T, Woolson R, Pe\u2019er J, Gruman L (1993) The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 100:1389\u20131398","journal-title":"Ophthalmology"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1016\/S0959-8049(96)00377-2","volume":"32A","author":"F Pezzella","year":"1996","unstructured":"Pezzella F, Dibacco A, Andreola S, Nicholson AG, Pastorino U, Harris AL (1996) Angiogenesis in primary lung-cancer and lung secondaries. Eur J Cancer 32A:2494\u20132500","journal-title":"Eur J Cancer"},{"issue":"6","key":"1_CR56","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/modpathol.2013.195","volume":"27","author":"C Balsat","year":"2014","unstructured":"Balsat C, Signolle N, Goffin F, Delbecque K, Plancoulaine B, Sauthier P, Samouelian V, Beliard A, Munaut C, Foidart JM et al (2014) Improved computer-assisted analysis of the global lymphatic network in human cervical tissues. Mod Pathol 27(6):887\u2013898","journal-title":"Mod Pathol"},{"issue":"3","key":"1_CR57","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0026-2862(92)90085-4","volume":"44","author":"S Wakui","year":"1992","unstructured":"Wakui S (1992) Epidermal growth factor receptor at endothelial cell and pericyte interdigitation in human granulation tissue. Microvasc Res 44(3):255\u2013262","journal-title":"Microvasc Res"},{"key":"1_CR58","first-page":"88","volume":"15","author":"D Visscher","year":"1993","unstructured":"Visscher D, Smilanetz S, Drozdowicz S, Wykes S (1993) Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. Anal Quant Cytol 15:88\u201392","journal-title":"Anal Quant Cytol"},{"issue":"3","key":"1_CR59","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/path.1711770310","volume":"177","author":"SB Fox","year":"1995","unstructured":"Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL (1995) Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 177(3):275\u2013283","journal-title":"J Pathol"},{"key":"1_CR60","first-page":"22A","volume":"70","author":"J Simpson","year":"1994","unstructured":"Simpson J, Ahn C, Battifora H, Esteban J (1994) Vascular surface area as a prognostic indicator in invasive breast carcinoma. Lab Invest 70:22A","journal-title":"Lab Invest"},{"issue":"3","key":"1_CR61","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/1097-0142(19940201)73:3<678::AID-CNCR2820730329>3.0.CO;2-6","volume":"73","author":"MK Brawer","year":"1994","unstructured":"Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA (1994) Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 73(3):678\u2013687","journal-title":"Cancer"},{"issue":"6","key":"1_CR62","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/bjc.1994.480","volume":"70","author":"M Furusato","year":"1994","unstructured":"Furusato M, Wakui S, Sasaki H, Ito K, Ushigome S (1994) Tumour angiogenesis in latent prostatic carcinoma. Br J Cancer 70(6):1244\u20131246","journal-title":"Br J Cancer"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/0046-8177(93)90304-Y","volume":"24","author":"S Bigler","year":"1993","unstructured":"Bigler S, Deering R, Brawer M (1993) Comparisons of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 24:220\u2013226","journal-title":"Hum Pathol"},{"issue":"5","key":"1_CR64","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0002-9610(05)80079-0","volume":"168","author":"JK Williams","year":"1994","unstructured":"Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewicz MJ (1994) Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 168(5):373\u2013380","journal-title":"Am J Surg"},{"issue":"4","key":"1_CR65","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0046-8177(98)90115-0","volume":"29","author":"P Wesseling","year":"1998","unstructured":"Wesseling P, van der Laak JA, Link M, Teepen HL, Ruiter DJ (1998) Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy. Hum Pathol 29(4):352\u2013358","journal-title":"Hum Pathol"},{"issue":"4","key":"1_CR66","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/ajcp\/103.4.443","volume":"103","author":"C Charpin","year":"1995","unstructured":"Charpin C, Devictor B, Bergeret D, Andrac L, Boulat J, Horschowski N, Lavaut MN, Piana L (1995) CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors. Am J Clin Pathol 103(4):443\u2013448","journal-title":"Am J Clin Pathol"},{"key":"1_CR67","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/(SICI)1096-9896(199802)184:2<136::AID-PATH970>3.0.CO;2-9","volume":"184","author":"J Laak Van der","year":"1998","unstructured":"Van der Laak J, Westphal J, Schalkwijk L, Pahplazt M, Ruiter D, de Waal R, de Wilde P (1998) An improved procedure to quantify tumour vascularity using true colour image analysis: comparison with the manual hot-spot procedure in a human melanoma xenograft model. J Pathol 184:136\u2013143","journal-title":"J Pathol"},{"issue":"3","key":"1_CR68","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.prp.2013.11.010","volume":"210","author":"Y Karslioglu","year":"2014","unstructured":"Karslioglu Y, Yigit N, Onguru O (2014) Chalkley method in the angiogenesis research and its automation via computer simulation. Pathol Res Pract 210(3):161\u2013168","journal-title":"Pathol Res Pract"},{"issue":"4","key":"1_CR69","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s13402-013-0139-3","volume":"36","author":"TF Hansen","year":"2013","unstructured":"Hansen TF, Nielsen BS, Jakobsen A, Sorensen FB (2013) Visualising and quantifying angiogenesis in metastatic colorectal cancer: a comparison of methods and their predictive value for chemotherapy response. Cell Oncol 36(4):341\u2013350","journal-title":"Cell Oncol"},{"issue":"8","key":"1_CR70","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.humpath.2012.11.023","volume":"44","author":"ZM Mohammed","year":"2013","unstructured":"Mohammed ZM, Orange C, McMillan DC, Mallon E, Doughty JC, Edwards J, Going JJ (2013) Comparison of visual and automated assessment of microvessel density and their impact on outcome in primary operable invasive ductal breast cancer. Hum Pathol 44(8):1688\u20131695","journal-title":"Hum Pathol"},{"issue":"4","key":"1_CR71","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00428-008-0657-y","volume":"453","author":"S Asioli","year":"2008","unstructured":"Asioli S, Eusebi V, Gaetano L, Losi L, Bussolati G (2008) The pre-lymphatic pathway, the roots of the lymphatic system in breast tissue: a 3D study. Virchows Arch 453(4):401\u2013406","journal-title":"Virchows Arch"},{"issue":"3","key":"1_CR72","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.mvr.2010.09.005","volume":"80","author":"A Ieva Di","year":"2010","unstructured":"Di Ieva A (2010) Angioarchitectural morphometrics of brain tumors: are there any potential histopathological biomarkers? Microvasc Res 80(3):522\u2013533","journal-title":"Microvasc Res"},{"issue":"11","key":"1_CR73","doi-asserted-by":"publisher","first-page":"e27385","DOI":"10.1371\/journal.pone.0027385","volume":"6","author":"E Zudaire","year":"2011","unstructured":"Zudaire E, Gambardella L, Kurcz C, Vermeren S (2011) A computational tool for quantitative analysis of vascular networks. PLoS One 6(11):e27385","journal-title":"PLoS One"},{"issue":"10","key":"1_CR74","doi-asserted-by":"publisher","first-page":"e75954","DOI":"10.1371\/journal.pone.0075954","volume":"8","author":"LT Mikalsen","year":"2013","unstructured":"Mikalsen LT, Dhakal HP, Bruland OS, Naume B, Borgen E, Nesland JM, Olsen DR (2013) The clinical impact of mean vessel size and solidity in breast carcinoma patients. PLoS One 8(10):e75954","journal-title":"PLoS One"},{"issue":"12","key":"1_CR75","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/0165-6147(91)90637-8","volume":"12","author":"SA McCarthy","year":"1991","unstructured":"McCarthy SA, Kuzu I, Gatter KC, Bicknell R (1991) Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis. Trends Pharmacol Sci 12(12):462\u2013467","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"1_CR76","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/bjc.1991.250","volume":"64","author":"P Carnochan","year":"1991","unstructured":"Carnochan P, Briggs JC, Westbury G, Davies AJ (1991) The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85\u20131.25 mm in thickness. Br J Cancer 64(1):102\u2013107","journal-title":"Br J Cancer"},{"key":"1_CR77","first-page":"709","volume":"14","author":"S Vesalainen","year":"1994","unstructured":"Vesalainen S, Lipponen P, Talja M, Alhava E, Syrjanen K (1994) Tumor vascularity and basement membrane structure as prognostic factors in T1-2M0 prostatic adenocarcinoma. Anticancer Res 14:709\u2013714","journal-title":"Anticancer Res"},{"issue":"8","key":"1_CR78","first-page":"1141","volume":"29A","author":"ME Hoef Van","year":"1993","unstructured":"Van Hoef ME, Knox WF, Dhesi SS, Howell A, Schor AM (1993) Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 29A(8):1141\u20131145","journal-title":"Eur J Cancer"},{"issue":"3","key":"1_CR79","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0960-7404(92)90068-V","volume":"1","author":"NR Hall","year":"1992","unstructured":"Hall NR, Fish DE, Hunt N, Goldin RD, Guillou PJ, Monson JR (1992) Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol 1(3):223\u2013229","journal-title":"Surg Oncol"},{"key":"1_CR80","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF01807282","volume":"11","author":"A Ottinetti","year":"1988","unstructured":"Ottinetti A, Sapino A (1988) Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions. Breast Cancer Res Treat 11:241\u2013248","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"1_CR81","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0046-8177(92)90344-3","volume":"23","author":"S Bosari","year":"1992","unstructured":"Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML (1992) Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23(7):755\u2013761","journal-title":"Hum Pathol"},{"key":"1_CR82","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/bjs.1800810603","volume":"81","author":"N Bundred","year":"1994","unstructured":"Bundred N, Bowcott M, Walls J, Faragher E, Knox F (1994) Angiogenesis in breast cancer predicts node metastasis and survival. Br J Surg 81:768 (Abstract)","journal-title":"Br J Surg"},{"issue":"8915","key":"1_CR83","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(94)91280-7","volume":"344","author":"VW Li","year":"1994","unstructured":"Li VW, Folkerth RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Black PM, Sallan SE, Folkman J (1994) Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344(8915):82\u201386","journal-title":"Lancet"},{"key":"1_CR84","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1136\/jcp.43.9.752","volume":"43","author":"D Parums","year":"1990","unstructured":"Parums D, Cordell J, Micklem K, Heryet A, Gatter K, Mason D (1990) JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 43:752\u2013757","journal-title":"J Clin Pathol"},{"issue":"71","key":"1_CR85","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1749-6632.1993.tb17192.x","volume":"698","author":"ER Horak","year":"1993","unstructured":"Horak ER, Harris AL, Stuart N, Bicknell R (1993) Angiogenesis in breast cancer. Regulation, prognostic aspects, and implications for novel treatment strategies. Ann N Y Acad Sci 698(71):71\u201384","journal-title":"Ann N Y Acad Sci"},{"key":"1_CR86","first-page":"22A","volume":"70","author":"H Sightler","year":"1994","unstructured":"Sightler H, Borowsky A, Dupont W, Page D, Jensen R (1994) Evaluation of tumor angiogenesis as a prognostic marker in breast cancer. Lab Invest 70:22A (abstract)","journal-title":"Lab Invest"},{"issue":"3","key":"1_CR87","first-page":"331","volume":"67","author":"RL Barnhill","year":"1992","unstructured":"Barnhill RL, Fandrey K, Levy MA, Mihm MJ, Hyman B (1992) Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab Invest 67(3):331\u2013337","journal-title":"Lab Invest"},{"key":"1_CR88","first-page":"17A","volume":"5","author":"A Sahin","year":"1992","unstructured":"Sahin A, Sneige N, Singletary E, Ayala A (1992) Tumor angiogenesis detected by Factor-VIII immunostaining in node-negative breast carcinoma (NNBC): a possible predictor of distant metastasis. Mod Pathol 5:17A (abstract)","journal-title":"Mod Pathol"},{"issue":"13","key":"1_CR89","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/jnci\/87.13.997","volume":"87","author":"K Axelsson","year":"1995","unstructured":"Axelsson K, Ljung BM, Moore DH II, Thor AD, Chew KL, Edgerton SM, Smith HS, Mayall BH (1995) Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma [see comments]. J Natl Cancer Inst 87(13):997\u20131008","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1_CR90","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF00666186","volume":"29","author":"SB Fox","year":"1994","unstructured":"Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL (1994) Tumor angiogenesis in node-negative breast carcinomas\u2014relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat 29(1):109\u2013116","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1_CR91","first-page":"139","volume":"6","author":"S Hansen","year":"2000","unstructured":"Hansen S, Grabau DA, Sorensen FB, Bak M, Vach W, Rose C (2000) The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 6(1):139\u2013146","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1_CR92","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/j.1464-410X.1994.tb07122.x","volume":"74","author":"AJ Dickinson","year":"1994","unstructured":"Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GN, Harris AL (1994) Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 74(6):762\u2013766","journal-title":"Br J Urol"},{"issue":"3","key":"1_CR93","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S1040-8428(89)80002-2","volume":"9","author":"N Paweletz","year":"1989","unstructured":"Paweletz N, Knierim M (1989) Tumor-related angiogenesis. Crit Rev Oncol Hematol 9(3):197\u2013242","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"1_CR94","first-page":"89","volume":"1032","author":"CH Blood","year":"1990","unstructured":"Blood CH, Zetter BR (1990) Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1032(1):89\u2013118","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1_CR95","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/0046-8177(95)90119-1","volume":"26","author":"LF Brown","year":"1995","unstructured":"Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ (1995) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 26(1):86\u201391","journal-title":"Hum Pathol"},{"issue":"48","key":"1_CR96","doi-asserted-by":"publisher","first-page":"12141","DOI":"10.1021\/bi00163a024","volume":"31","author":"A Moghaddam","year":"1992","unstructured":"Moghaddam A, Bicknell R (1992) Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 31(48):12141\u201312146","journal-title":"Biochemistry"},{"issue":"4","key":"1_CR97","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/bjc.1994.146","volume":"69","author":"SY Anandappa","year":"1994","unstructured":"Anandappa SY, Winstanley JH, Leinster S, Green B, Rudland PS, Barraclough R (1994) Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br J Cancer 69(4):772\u2013776","journal-title":"Br J Cancer"},{"issue":"5","key":"1_CR98","first-page":"963","volume":"57","author":"M Relf","year":"1997","unstructured":"Relf M, LeJeune S, Scott PA, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R, Harris AL (1997) Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57(5):963\u2013969","journal-title":"Cancer Res"},{"issue":"5","key":"1_CR99","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/1097-0142(19940901)74:5<1584::AID-CNCR2820740514>3.0.CO;2-V","volume":"74","author":"RJ Garver","year":"1994","unstructured":"Garver RJ, Radford DM, Donis KH, Wick MR, Milner PG (1994) Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer 74(5):1584\u20131590","journal-title":"Cancer"},{"issue":"6","key":"1_CR100","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1023\/A:1008303614441","volume":"10","author":"K Smith","year":"1999","unstructured":"Smith K, Fox SB, Whitehouse R, Taylor M, Greenall M, Clarke J, Harris AL (1999) Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival. Ann Oncol 10(6):707\u2013713","journal-title":"Ann Oncol"},{"issue":"6","key":"1_CR101","first-page":"1473","volume":"140","author":"SY Wong","year":"1992","unstructured":"Wong SY, Purdie AT, Han P (1992) Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study. Am J Pathol 140(6):1473\u20131482","journal-title":"Am J Pathol"},{"key":"1_CR102","first-page":"665","volume":"8","author":"DW Visscher","year":"1995","unstructured":"Visscher DW, DeMattia F, Ottosen S, Sarkar FH, Crissman JD (1995) Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma. Mod Pathol 8:665\u2013670","journal-title":"Mod Pathol"},{"issue":"10","key":"1_CR103","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrclinonc.2009.130","volume":"6","author":"SP Ivy","year":"2009","unstructured":"Ivy SP, Wick JY, Kaufman BM (2009) An overview of small-molecule inhibitors of VEGFR signaling. Nat Rev Clin Oncol 6(10):569\u2013579","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"1_CR104","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1053\/j.seminoncol.2014.02.007","volume":"41","author":"K Mittal","year":"2014","unstructured":"Mittal K, Ebos J, Rini B (2014) Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond. Semin Oncol 41(2):235\u2013251","journal-title":"Semin Oncol"},{"key":"1_CR105","unstructured":"FDA approval for bevacizumab. http:\/\/www.cancer.gov\/cancertopics\/druginfo\/fda-bevacizumab"},{"key":"1_CR106","unstructured":"Proposal to withdraw approval for the breast cancer indication for Avastin (bevacizumab). http:\/\/www.fda.gov\/downloads\/NewsEvents\/Newsroom\/UCM280546.pdf"},{"key":"1_CR107","unstructured":"FDA approval for sunitinib malate. http:\/\/www.cancer.gov\/cancertopics\/druginfo\/fda-sunitinib-malate"},{"key":"1_CR108","unstructured":"FDA approval for sorafenib tosylate. http:\/\/www.cancer.gov\/cancertopics\/druginfo\/fda-sorafenib-tosylate"},{"issue":"6","key":"1_CR109","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/(SICI)1097-0142(19960315)77:6<1101::AID-CNCR15>3.0.CO;2-5","volume":"77","author":"M Toi","year":"1996","unstructured":"Toi M, Kondo S, Suzuki H, Yamamoto Y, Inada K, Imazawa T, Taniguchi T, Tominaga T (1996) Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer 77(6):1101\u20131106","journal-title":"Cancer"},{"issue":"3","key":"1_CR110","first-page":"1925","volume":"22","author":"T Lantzsch","year":"2002","unstructured":"Lantzsch T, Hefler L, Krause U, Kehl A, Goepel C, Koelbl H, Dunst J, Lampe D (2002) The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer. Anticancer Res 22(3):1925\u20131928","journal-title":"Anticancer Res"},{"issue":"6","key":"1_CR111","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s004280100458","volume":"440","author":"T Valkovic","year":"2002","unstructured":"Valkovic T, Dobrila F, Melato M, Sasso F, Rizzardi C, Jonjic N (2002) Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Virchows Arch 440(6):583\u2013588","journal-title":"Virchows Arch"},{"issue":"9","key":"1_CR112","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.1998.16.9.3121","volume":"16","author":"B Linderholm","year":"1998","unstructured":"Linderholm B, Tavelin B, Grankvist K, Henriksson R (1998) Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J Clin Oncol 16(9):3121\u20133128","journal-title":"J Clin Oncol"},{"issue":"2","key":"1_CR113","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/jnci\/89.2.139","volume":"89","author":"G Gasparini","year":"1997","unstructured":"Gasparini G, Toi M, Gion M, Verderio P, Dittadi R, Hanatani M, Matsubara I, Vinante O, Bonoldi E, Boracchi P et al (1997) Prognostic-significance of vascular endothelial growth-factor protein in node-negative breast-carcinoma. J Natl Cancer Inst 89(2):139\u2013147","journal-title":"J Natl Cancer Inst"},{"issue":"16","key":"1_CR114","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/jnci\/89.16.1212","volume":"89","author":"A Obermair","year":"1997","unstructured":"Obermair A, Bancher-Todesca D, Bilgi S, Kaider A, Kohlberger P, Mullauer-Ertl S, Leodolter S, Gitsch G (1997) Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. J Natl Cancer Inst 89(16):1212\u20131217","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"1_CR115","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/sj.bjc.6600555","volume":"87","author":"P Manders","year":"2002","unstructured":"Manders P, Beex LV, Tjan-Heijnen VC, Geurts-Moespot J, Van Tienoven TH, Foekens JA, Sweep CG (2002) The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy. Br J Cancer 87(7):772\u2013778","journal-title":"Br J Cancer"},{"issue":"9","key":"1_CR116","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1200\/JCO.1998.16.9.3129","volume":"16","author":"U Eppenberger","year":"1998","unstructured":"Eppenberger U, Kueng W, Schlaeppi JM, Roesel JL, Benz C, Mueller H, Matter A, Zuber M, Luescher K, Litschgi M et al (1998) Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J Clin Oncol 16(9):3129\u20133136","journal-title":"J Clin Oncol"},{"issue":"6","key":"1_CR117","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1054\/bjoc.2001.2019","volume":"85","author":"D Coradini","year":"2001","unstructured":"Coradini D, Boracchi P, Daidone MG, Pellizzaro C, Miodini P, Ammatuna M, Tomasic G, Biganzoli E (2001) Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer. Br J Cancer 85(6):795\u2013797","journal-title":"Br J Cancer"},{"issue":"1","key":"1_CR118","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ijc.10121","volume":"98","author":"M Toi","year":"2002","unstructured":"Toi M, Bando H, Ogawa T, Muta M, Hornig C, Weich HA (2002) Significance of vascular endothelial growth factor (VEGF)\/soluble VEGF receptor-1 relationship in breast cancer. Int J Cancer 98(1):14\u201318","journal-title":"Int J Cancer"},{"issue":"1","key":"1_CR119","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6890-14-5","volume":"14","author":"TK Kilvaer","year":"2014","unstructured":"Kilvaer TK, Smeland E, Valkov A, Sorbye SW, Bremnes RM, Busund LT, Donnem T (2014) The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk. BMC Clin Pathol 14(1):5","journal-title":"BMC Clin Pathol"},{"issue":"4","key":"1_CR120","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1309\/X6NXYE57DLUE2NQ8","volume":"127","author":"YM El-Gohary","year":"2007","unstructured":"El-Gohary YM, Silverman JF, Olson PR, Liu YL, Cohen JK, Miller R, Saad RS (2007) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma. Am J Clin Pathol 127(4):572\u2013579","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"1_CR121","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/modpathol.3800034","volume":"17","author":"RS Saad","year":"2004","unstructured":"Saad RS, Liu YL, Nathan G, Celebrezze J, Medich D, Silverman JF (2004) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol 17(2):197\u2013203","journal-title":"Mod Pathol"},{"issue":"10","key":"1_CR122","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.ejso.2014.01.004","volume":"40","author":"D Georgiadou","year":"2014","unstructured":"Georgiadou D, Sergentanis TN, Sakellariou S, Filippakis GM, Zagouri F, Vlachodimitropoulos D, Psaltopoulou T, Lazaris AC, Patsouris E, Zografos GC (2014) VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis. Eur J Surg Oncol 40(10):1331\u20131337","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"1_CR123","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/neup.12111","volume":"34","author":"CA Clara","year":"2014","unstructured":"Clara CA, Marie SK, de Almeida JR, Wakamatsu A, Oba-Shinjo SM, Uno M, Neville M, Rosemberg S (2014) Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1alpha in human glioblastoma. Neuropathology 34(4):343\u2013352","journal-title":"Neuropathology"},{"key":"1_CR124","first-page":"4278","volume":"6","author":"S Gunningham","year":"2000","unstructured":"Gunningham S, Currie M, Cheng H, Scott P, Robinson B, Harris A, Fox S (2000) The short form of the alternatively spliced flt-4 but not its ligand VEGF-C is related to lymph node metastasis in human breast cancers. Clin Cancer Res 6:4278\u20134286","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1_CR125","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1023\/A:1010692132669","volume":"66","author":"J Kinoshita","year":"2001","unstructured":"Kinoshita J, Kitamura K, Kabashima A, Saeki H, Tanaka S, Sugimachi K (2001) Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer Res Treat 66(2):159\u2013164","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1_CR126","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/path.814","volume":"193","author":"SP Gunningham","year":"2001","unstructured":"Gunningham SP, Currie MJ, Han C, Robinson BA, Scott PA, Harris AL, Fox SB (2001) VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis. J Pathol 193(3):325\u2013332","journal-title":"J Pathol"},{"issue":"1","key":"1_CR127","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1349-7006.2004.tb03167.x","volume":"95","author":"S Onogawa","year":"2004","unstructured":"Onogawa S, Kitadai Y, Tanaka S, Kuwai T, Kimura S, Chayama K (2004) Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci 95(1):32\u201339","journal-title":"Cancer Sci"},{"issue":"4","key":"1_CR128","first-page":"1361","volume":"9","author":"Y Yokoyama","year":"2003","unstructured":"Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, Emoto M, Sakamoto A, Sakamoto T, Maruyama H et al (2003) Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res 9(4):1361\u20131369","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1_CR129","first-page":"716","volume":"9","author":"Y Nakamura","year":"2003","unstructured":"Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K (2003) Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. Clin Cancer Res 9(2):716\u2013721","journal-title":"Clin Cancer Res"},{"issue":"9","key":"1_CR130","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1349-7006.1999.tb00844.x","volume":"90","author":"J Kurebayashi","year":"1999","unstructured":"Kurebayashi J, Otsuki T, Kunisue H, Mikami Y, Tanaka K, Yamamoto S, Sonoo H (1999) Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. Jpn J Cancer Res 90(9):977\u2013981","journal-title":"Jpn J Cancer Res"},{"issue":"4","key":"1_CR131","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/(SICI)1096-9896(199708)182:4<414::AID-PATH897>3.0.CO;2-Q","volume":"182","author":"K Engels","year":"1997","unstructured":"Engels K, Fox SB, Whitehouse RM, Gatter KC, Harris AL (1997) Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomas in situ of the breast. J Pathol 182(4):414\u2013420","journal-title":"J Pathol"},{"issue":"3","key":"1_CR132","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/bjc.1996.49","volume":"73","author":"SB Fox","year":"1996","unstructured":"Fox SB, Westwood M, Moghaddam A, Comley M, Turley H, Whitehouse RM, Bicknell R, Gatter KC, Harris AL (1996) The angiogenic factor platelet-derived endothelial cell growth factor\/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 73(3):275\u2013280","journal-title":"Br J Cancer"},{"key":"1_CR133","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ijc.2910640202","volume":"64","author":"M Toi","year":"1995","unstructured":"Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T (1995) Expression of platelet derived endothelial cell growth factor\/thymidine phosphorylase in human breast cancer. Int J Cancer 64:79\u201382","journal-title":"Int J Cancer"},{"issue":"5","key":"1_CR134","first-page":"1131","volume":"5","author":"M Toi","year":"1999","unstructured":"Toi M, Ueno T, Matsumoto H, Saji H, Funata N, Koike M, Tominaga T (1999) Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer. Clin Cancer Res 5(5):1131\u20131137","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1_CR135","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ijc.1633","volume":"97","author":"Q Yang","year":"2002","unstructured":"Yang Q, Barbareschi M, Mori I, Mauri F, Muscara M, Nakamura M, Nakamura Y, Yoshimura G, Sakurai T, Caffo O et al (2002) Prognostic value of thymidine phosphorylase expression in breast carcinoma. Int J Cancer 97(4):512\u2013517","journal-title":"Int J Cancer"},{"issue":"5","key":"1_CR136","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/ijc.10105","volume":"97","author":"A Kanzaki","year":"2002","unstructured":"Kanzaki A, Takebayashi Y, Bando H, Eliason JF, Watanabe Si S, Miyashita H, Fukumoto M, Toi M, Uchida T (2002) Expression of uridine and thymidine phosphorylase genes in human breast carcinoma. Int J Cancer 97(5):631\u2013635","journal-title":"Int J Cancer"},{"issue":"3","key":"1_CR137","first-page":"449","volume":"13","author":"H Nagaoka","year":"1998","unstructured":"Nagaoka H, Iino Y, Takei H, Morishita Y (1998) Platelet-derived endothelial cell growth factor\/thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in invasive breast cancer. Int J Oncol 13(3):449\u2013454","journal-title":"Int J Oncol"},{"key":"1_CR138","first-page":"961","volume":"1","author":"M Toi","year":"1995","unstructured":"Toi M, Yamamoto Y, Inada K, Hoshina S, Suzuki H, Kondo S, Tominaga T (1995) Vascular endothelial growth factor and platelet-derived endothelial growth factor are frequently co-expressed in highly vascularized breast cancer. Clin Cancer Res 1:961\u2013964","journal-title":"Clin Cancer Res"},{"key":"1_CR139","first-page":"4799","volume":"56","author":"T O\u2019Brien","year":"1996","unstructured":"O\u2019Brien T, Fox S, Dickinson A, Turley H, Westwood M, Moghaddam A, Gatter K, Bicknell R, Harris A (1996) Expression of the angiogenic factor thymidine phosphorylase\/platelet derived endothelial cell growth factor in primary bladder cancers. Cancer Res 56:4799\u20134804","journal-title":"Cancer Res"},{"issue":"3","key":"1_CR140","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1464-410X.1995.tb07706.x","volume":"76","author":"TS O\u2019Brien","year":"1995","unstructured":"O\u2019Brien TS, Smith K, Cranston D, Fuggle S, Bicknell R, Harris AL (1995) Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy. Br J Urol 76(3):311\u2013314","journal-title":"Br J Urol"},{"issue":"11","key":"1_CR141","first-page":"2898","volume":"60","author":"J Adams","year":"2000","unstructured":"Adams J, Carder PJ, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker JJ et al (2000) Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res 60(11):2898\u20132905","journal-title":"Cancer Res"},{"issue":"8","key":"1_CR142","first-page":"2121","volume":"5","author":"A Freeman","year":"1999","unstructured":"Freeman A, Morris LS, Mills AD, Stoeber K, Laskey RA, Williams GH, Coleman N (1999) Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 5(8):2121\u20132132","journal-title":"Clin Cancer Res"},{"issue":"14","key":"1_CR143","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/jnci\/94.14.1071","volume":"94","author":"K Stoeber","year":"2002","unstructured":"Stoeber K, Swinn R, Prevost AT, de Clive-Lowe P, Halsall I, Dilworth SM, Marr J, Turner WH, Bullock N, Doble A et al (2002) Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J Natl Cancer Inst 94(14):1071\u20131079","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"1_CR144","first-page":"1388","volume":"60","author":"A Eberhard","year":"2000","unstructured":"Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG (2000) Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 60(5):1388\u20131393","journal-title":"Cancer Res"},{"issue":"4","key":"1_CR145","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.3390\/ijms15045663","volume":"15","author":"V Barresi","year":"2014","unstructured":"Barresi V, Branca G, Caffo M, Caltabiano R, Ieni A, Vitarelli E, Lanzafame S, Tuccari G (2014) Immuno-expression of endoglin and smooth muscle actin in the vessels of brain metastases. Is there a rational for anti-angiogenic therapy? Int J Mol Sci 15(4):5663\u20135679","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1_CR146","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.semcancer.2009.05.004","volume":"19","author":"C Francavilla","year":"2009","unstructured":"Francavilla C, Maddaluno L, Cavallaro U (2009) The functional role of cell adhesion molecules in tumor angiogenesis. Semin Cancer Biol 19(5):298\u2013309","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"1_CR147","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/ncb2926","volume":"16","author":"K Bentley","year":"2014","unstructured":"Bentley K, Franco CA, Philippides A, Blanco R, Dierkes M, Gebala V, Stanchi F, Jones M, Aspalter IM, Cagna G et al (2014) The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Nat Cell Biol 16(4):309\u2013321","journal-title":"Nat Cell Biol"},{"key":"1_CR148","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/jnci\/87.5.366","volume":"87","author":"D Schadendorf","year":"1995","unstructured":"Schadendorf D, Heidel J, Gawlik C, Suter L, Czarnetzki BM (1995) Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst 87:366\u2013371","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"1_CR149","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s002620000124","volume":"49","author":"T Kageshita","year":"2000","unstructured":"Kageshita T, Hamby CV, Hirai S, Kimura T, Ono T, Ferrone S (2000) Alpha(v)beta3 expression on blood vessels and melanoma cells in primary lesions: differential association with tumor progression and clinical prognosis. Cancer Immunol Immunother 49(6):314\u2013318","journal-title":"Cancer Immunol Immunother"},{"key":"1_CR150","first-page":"4927","volume":"53","author":"T Kageshita","year":"1993","unstructured":"Kageshita T, Yoshii A, Kimura T, Kuriya N, Ono T, Tsujisaki M, Imai K, Ferrone S (1993) Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res 53:4927\u20134932","journal-title":"Cancer Res"},{"issue":"1","key":"1_CR151","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/bjc.1993.298","volume":"68","author":"RE Banks","year":"1993","unstructured":"Banks RE, Gearing AJ, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ (1993) Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 68(1):122\u2013124","journal-title":"Br J Cancer"},{"key":"1_CR152","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1172\/JCI118227","volume":"96","author":"PC Brooks","year":"1995","unstructured":"Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA (1995) Antiintegrin \u03b23\u03b1v blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 96:1815\u20131822","journal-title":"J Clin Invest"},{"issue":"11","key":"1_CR153","first-page":"2625","volume":"4","author":"G Gasparini","year":"1998","unstructured":"Gasparini G, Brooks PC, Biganzoli E, Vermeulen PB, Bonoldi E, Dirix LY, Ranieri G, Miceli R, Cheresh DA (1998) Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. Clin Cancer Res 4(11):2625\u20132634","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1_CR154","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/annonc\/mds505","volume":"24","author":"A Heidenreich","year":"2013","unstructured":"Heidenreich A, Rawal SK, Szkarlat K, Bogdanova N, Dirix L, Stenzl A, Welslau M, Wang G, Dawkins F, de Boer CJ et al (2013) A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human alphanu integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer. Ann Oncol 24(2):329\u2013336","journal-title":"Ann Oncol"},{"issue":"1","key":"1_CR155","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10637-012-9842-6","volume":"31","author":"C Manegold","year":"2013","unstructured":"Manegold C, Vansteenkiste J, Cardenal F, Schuette W, Woll PJ, Ulsperger E, Kerber A, Eckmayr J, von Pawel J (2013) Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer. Invest New Drugs 31(1):175\u2013182","journal-title":"Invest New Drugs"},{"issue":"3","key":"1_CR156","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/bjc.2011.183","volume":"105","author":"S O\u2019Day","year":"2011","unstructured":"O\u2019Day S, Pavlick A, Loquai C, Lawson D, Gutzmer R, Richards J, Schadendorf D, Thompson JA, Gonzalez R, Trefzer U et al (2011) A randomised, phase II study of intetumumab, an anti-alphav-integrin mAb, alone and with dacarbazine in stage IV melanoma. Br J Cancer 105(3):346\u2013352","journal-title":"Br J Cancer"},{"issue":"4","key":"1_CR157","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/CMR.0b013e32835312e4","volume":"22","author":"KB Kim","year":"2012","unstructured":"Kim KB, Prieto V, Joseph RW, Diwan AH, Gallick GE, Papadopoulos NE, Bedikian AY, Camacho LH, Hwu P, Ng CS et al (2012) A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma. Melanoma Res 22(4):294\u2013301","journal-title":"Melanoma Res"},{"issue":"10","key":"1_CR158","first-page":"4213","volume":"32","author":"C Scaringi","year":"2012","unstructured":"Scaringi C, Minniti G, Caporello P, Enrici RM (2012) Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results. Anticancer Res 32(10):4213\u20134223","journal-title":"Anticancer Res"},{"key":"1_CR159","unstructured":"Stupp R, Hegi ME, Gorlia T, Perry JR, Erridge S, Reardons DA, Markivskyy A, Wick W, Hong YK, Weller M (2013) Standard chemotherapy +\/\u2212 cilengitide in newly diagnosed glioblastoma (GBM): updated results and subgroup analyses of the international randomized phase III CENTRIC trial (EORTC trial #26071-22072\/Canadian Brain Tumor Consortium). In: European Multidisciplinary Cancer Congress 2013, vol 49. Eur J Cancer, Amsterdam, p S775"},{"issue":"7","key":"1_CR160","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/hq0701.093685","volume":"21","author":"MS Pepper","year":"2001","unstructured":"Pepper MS (2001) Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21(7):1104\u20131117","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1_CR161","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/BF03032599","volume":"7","author":"A John","year":"2001","unstructured":"John A, Tuszynski G (2001) The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7(1):14\u201323","journal-title":"Pathol Oncol Res"},{"issue":"3\u20134","key":"1_CR162","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S1050-1738(99)00014-6","volume":"9","author":"TL Haas","year":"1999","unstructured":"Haas TL, Madri JA (1999) Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: implications for angiogenesis. Trends Cardiovasc Med 9(3\u20134):70\u201377","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"1_CR163","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1699-0463.1999.tb01535.x","volume":"107","author":"A Lochter","year":"1999","unstructured":"Lochter A, Bissell MJ (1999) An odyssey from breast to bone: multi-step control of mammary metastases and osteolysis by matrix metalloproteinases. APMIS 107(1):128\u2013136","journal-title":"APMIS"},{"issue":"1","key":"1_CR164","first-page":"119","volume":"67","author":"YV Parfyonova","year":"2002","unstructured":"Parfyonova YV, Plekhanova OS, Tkachuk VA (2002) Plasminogen activators in vascular remodeling and angiogenesis. Biochemistry 67(1):119\u2013134","journal-title":"Biochemistry"},{"issue":"4","key":"1_CR165","first-page":"345","volume":"77","author":"BS Nielsen","year":"1997","unstructured":"Nielsen BS, Sehested M, Kjeldsen L, Borregaard N, Rygaard J, Dano K (1997) Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer. Lab Invest 77(4):345\u2013355","journal-title":"Lab Invest"},{"key":"1_CR166","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/path.931","volume":"195","author":"S Fox","year":"2001","unstructured":"Fox S, Taylor M, Grondahl-Hansen J, Kakolyris S, Gatter K, Harris A (2001) Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer. J Pathol 195:236\u2013243","journal-title":"J Pathol"},{"issue":"11","key":"1_CR167","first-page":"2513","volume":"53","author":"J Gr\u00f8ndahl-Hansen","year":"1993","unstructured":"Gr\u00f8ndahl-Hansen J, Christensen IJ, Rosenquist C, Brunner N, Mouridsen HT, Dan\u00f8 K, Blichert-Toft M (1993) High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res 53(11):2513\u20132521","journal-title":"Cancer Res"},{"key":"1_CR168","first-page":"1079","volume":"1","author":"J Gr\u00f8ndahl-Hansen","year":"1995","unstructured":"Gr\u00f8ndahl-Hansen J, Peters HA, van Putten WL, Look MP, Pappot H, R\u00f8nne E, Dan\u00f8 K, Klijn JGM, Brunner N, Foekens JA (1995) Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. Clin Cancer Res 1:1079\u20131087","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1_CR169","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1023\/A:1005744914124","volume":"43","author":"J Gr\u00f8ndahl-Hansen","year":"1997","unstructured":"Gr\u00f8ndahl-Hansen J, Hilsenbeck SG, Christensen IJ, Clark GM, Osborne CK, Br\u00fcnner N (1997) Prognostic significance of PAI-1 and uPA in cytosolic extracts obtained from node-positive breast cancer patients. Breast Cancer Res Treat 43(2):153\u2013163","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"1_CR170","first-page":"2527","volume":"54","author":"F Janicke","year":"1994","unstructured":"Janicke F, Pache L, Schmitt M, Ulm K, Thomssen C, Prechtl A, Graeff H (1994) Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1. Cancer Res 54(10):2527\u20132530","journal-title":"Cancer Res"},{"issue":"10","key":"1_CR171","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/jnci\/87.10.751","volume":"87","author":"JA Foekens","year":"1995","unstructured":"Foekens JA, Look MP, Peters HA, van Putten WL, Portengen H, Klijn JG (1995) Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer. J Natl Cancer Inst 87(10):751\u2013756","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"1_CR172","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/clinchem\/48.8.1194","volume":"48","author":"MJ Duffy","year":"2002","unstructured":"Duffy MJ (2002) Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studies. Clin Chem 48(8):1194\u20131197","journal-title":"Clin Chem"},{"issue":"3","key":"1_CR173","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3816\/CBC.2002.n.023","volume":"3","author":"N Harbeck","year":"2002","unstructured":"Harbeck N, Schmitt M, Kates RE, Kiechle M, Zemzoum I, Janicke F, Thomssen C (2002) Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts. Clin Breast Cancer 3(3):196\u2013200","journal-title":"Clin Breast Cancer"},{"key":"1_CR174","first-page":"216","volume":"53","author":"B Warren","year":"1972","unstructured":"Warren B, Greenblatt M, Kommineni V (1972) Tumor angiogenesis: ultrastructure of endothelial cells in mitosis. Br J Exp Pathol 53:216\u2013224","journal-title":"Br J Exp Pathol"},{"key":"1_CR175","first-page":"97","volume":"237","author":"HF Dvorak","year":"1999","unstructured":"Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM (1999) Vascular permeability factor\/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 237:97\u2013132","journal-title":"Curr Top Microbiol Immunol"},{"issue":"23","key":"1_CR176","first-page":"6449","volume":"49","author":"P Vaupel","year":"1989","unstructured":"Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49(23):6449\u20136465","journal-title":"Cancer Res"},{"issue":"1","key":"1_CR177","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris AL (2002) Hypoxia\u2014a key regulatory factor in tumour growth. Nat Rev Cancer 2(1):38\u201347","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1_CR178","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9440(10)64554-3","volume":"157","author":"KL Talks","year":"2000","unstructured":"Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL (2000) The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157(2):411\u2013421","journal-title":"Am J Pathol"},{"issue":"24","key":"1_CR179","first-page":"7075","volume":"60","author":"CC Wykoff","year":"2000","unstructured":"Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH et al (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60(24):7075\u20137083","journal-title":"Cancer Res"},{"issue":"17","key":"1_CR180","first-page":"6394","volume":"61","author":"JA Loncaster","year":"2001","unstructured":"Loncaster JA, Harris AL, Davidson SE, Logue JP, Hunter RD, Wycoff CC, Pastorek J, Ratcliffe PJ, Stratford IJ, West CM (2001) Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61(17):6394\u20136399","journal-title":"Cancer Res"},{"issue":"6","key":"1_CR181","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1002\/cncr.11246","volume":"97","author":"R Bos","year":"2003","unstructured":"Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E (2003) Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97(6):1573\u20131581","journal-title":"Cancer"},{"issue":"3","key":"1_CR182","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1200\/JCO.2003.11.132","volume":"21","author":"DE Swinson","year":"2003","unstructured":"Swinson DE, Jones JL, Richardson D, Wykoff C, Turley H, Pastorek J, Taub N, Harris AL, O\u2019Byrne KJ (2003) Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol 21(3):473\u2013482","journal-title":"J Clin Oncol"},{"issue":"4","key":"1_CR183","first-page":"818","volume":"7","author":"C Qin","year":"2001","unstructured":"Qin C, Wilson C, Blancher C, Taylor M, Safe S, Harris AL (2001) Association of ARNT splice variants with estrogen receptor-negative breast cancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis. Clin Cancer Res 7(4):818\u2013823","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1_CR184","first-page":"1831","volume":"8","author":"M Schindl","year":"2002","unstructured":"Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G et al (2002) Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 8(6):1831\u20131837","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1_CR185","first-page":"3003","volume":"25","author":"K Okada","year":"2005","unstructured":"Okada K, Osaki M, Araki K, Ishiguro K, Ito H, Ohgi S (2005) Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas. Anticancer Res 25(4):3003\u20133009","journal-title":"Anticancer Res"},{"issue":"2","key":"1_CR186","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-006-9190-3","volume":"99","author":"SF Schoppmann","year":"2006","unstructured":"Schoppmann SF, Fenzl A, Schindl M, Bachleitner-Hofmann T, Nagy K, Gnant M, Horvat R, Jakesz R, Birner P (2006) Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast Cancer Res Treat 99(2):135\u2013141","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"1_CR187","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/modpathol.3880555","volume":"15","author":"T Hasebe","year":"2002","unstructured":"Hasebe T, Sasaki S, Imoto S, Mukai K, Yokose T, Ochiai A (2002) Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Mod Pathol 15(5):502\u2013516","journal-title":"Mod Pathol"},{"issue":"4","key":"1_CR188","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1349-7006.1996.tb00234.x","volume":"87","author":"T Hasebe","year":"1996","unstructured":"Hasebe T, Tsuda H, Hirohashi S, Shimosato Y, Iwai M, Imoto S, Mukai K (1996) Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness. Jpn J Cancer Res 87(4):385\u2013394","journal-title":"Jpn J Cancer Res"},{"issue":"4","key":"1_CR189","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1365-2559.2007.02761.x","volume":"51","author":"GG Eynden Van den","year":"2007","unstructured":"Van den Eynden GG, Colpaert CG, Couvelard A, Pezzella F, Dirix LY, Vermeulen PB, Van Marck EA, Hasebe T (2007) A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation. Histopathology 51(4):440\u2013451","journal-title":"Histopathology"},{"issue":"9","key":"1_CR190","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1245\/s10434-013-2955-0","volume":"20","author":"SS Mujtaba","year":"2013","unstructured":"Mujtaba SS, Ni YB, Tsang JY, Chan SK, Yamaguchi R, Tanaka M, Tan PH, Tse GM (2013) Fibrotic focus in breast carcinomas: relationship with prognostic parameters and biomarkers. Ann Surg Oncol 20(9):2842\u20132849","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"1_CR191","first-page":"492","volume":"12","author":"Y Jitsuiki","year":"1999","unstructured":"Jitsuiki Y, Hasebe T, Tsuda H, Imoto S, Tsubono Y, Sasaki S, Mukai K (1999) Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast. Mod Pathol 12(5):492\u2013498","journal-title":"Mod Pathol"},{"issue":"2","key":"1_CR192","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1023\/A:1025702330207","volume":"81","author":"CG Colpaert","year":"2003","unstructured":"Colpaert CG, Vermeulen PB, Fox SB, Harris AL, Dirix LY, Van Marck EA (2003) The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis. Breast Cancer Res Treat 81(2):137\u2013147","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1_CR193","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrc3677","volume":"14","author":"SA Stacker","year":"2014","unstructured":"Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, Achen MG (2014) Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer 14(3):159\u2013172","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1_CR194","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/sj.bjc.6602844","volume":"93","author":"T Kato","year":"2005","unstructured":"Kato T, Prevo R, Steers G, Roberts H, Leek RD, Kimura T, Kameoka S, Nishikawa T, Kobayashi M, Jackson DG et al (2005) A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity. Br J Cancer 93(10):1168\u20131174","journal-title":"Br J Cancer"},{"key":"1_CR195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1413.001","volume":"1131","author":"P Baluk","year":"2008","unstructured":"Baluk P, McDonald DM (2008) Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann N Y Acad Sci 1131:1\u201312","journal-title":"Ann N Y Acad Sci"},{"issue":"22","key":"1_CR196","first-page":"8079","volume":"61","author":"C Mouta Carreira","year":"2001","unstructured":"Mouta Carreira C, Nasser SM, di Tomaso E, Padera TP, Boucher Y, Tomarev SI, Jain RK (2001) LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 61(22):8079\u20138084","journal-title":"Cancer Res"},{"issue":"46","key":"1_CR197","doi-asserted-by":"publisher","first-page":"33671","DOI":"10.1074\/jbc.M702889200","volume":"282","author":"LA Johnson","year":"2007","unstructured":"Johnson LA, Prevo R, Clasper S, Jackson DG (2007) Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J Biol Chem 282(46):33671\u201333680","journal-title":"J Biol Chem"},{"issue":"12","key":"1_CR198","doi-asserted-by":"publisher","first-page":"11153","DOI":"10.1007\/s11033-012-2024-y","volume":"39","author":"J Wang","year":"2012","unstructured":"Wang J, Guo Y, Wang B, Bi J, Li K, Liang X, Chu H, Jiang H (2012) Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature. Mol Biol Rep 39(12):11153\u201311165","journal-title":"Mol Biol Rep"},{"issue":"5","key":"1_CR199","doi-asserted-by":"publisher","first-page":"5331","DOI":"10.1007\/s11033-011-1332-y","volume":"39","author":"J Wang","year":"2012","unstructured":"Wang J, Li K, Wang B, Bi J (2012) Lymphatic microvessel density as a prognostic factor in non-small cell lung carcinoma: a meta-analysis of the literature. Mol Biol Rep 39(5):5331\u20135338","journal-title":"Mol Biol Rep"},{"issue":"7","key":"1_CR200","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/jso.21744","volume":"102","author":"H Kurahara","year":"2010","unstructured":"Kurahara H, Takao S, Shinchi H, Maemura K, Mataki Y, Sakoda M, Hayashi T, Kuwahata T, Minami K, Ueno S et al (2010) Significance of lymphangiogenesis in primary tumor and draining lymph nodes during lymphatic metastasis of pancreatic head cancer. J Surg Oncol 102(7):809\u2013815","journal-title":"J Surg Oncol"},{"issue":"3","key":"1_CR201","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/jso.21607","volume":"102","author":"SK Lee","year":"2010","unstructured":"Lee SK, Cho EY, Kim WW, Kim SH, Hur SM, Kim S, Choe JH, Kim JH, Kim JS, Lee JE et al (2010) The prediction of lymph node metastasis in ductal carcinoma in situ with microinvasion by assessing lymphangiogenesis. J Surg Oncol 102(3):225\u2013229","journal-title":"J Surg Oncol"},{"issue":"10","key":"1_CR202","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/modpathol.3800651","volume":"19","author":"RS Saad","year":"2006","unstructured":"Saad RS, Kordunsky L, Liu YL, Denning KL, Kandil HA, Silverman JF (2006) Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol 19(10):1317\u20131323","journal-title":"Mod Pathol"},{"issue":"11","key":"1_CR203","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.humpath.2010.12.020","volume":"42","author":"D Minardi","year":"2011","unstructured":"Minardi D, d\u2019Anzeo G, Lucarini G, Filosa A, Zizzi A, Simonetti O, Polito M Jr, Offidani AM, Di Primio R, Montironi R et al (2011) D2-40 immunoreactivity in penile squamous cell carcinoma: a marker of aggressiveness. Hum Pathol 42(11):1596\u20131602","journal-title":"Hum Pathol"},{"issue":"4","key":"1_CR204","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10120-012-0216-8","volume":"16","author":"J Rudno-Rudzinska","year":"2013","unstructured":"Rudno-Rudzinska J, Kielan W, Grzebieniak Z, Dziegiel P, Donizy P, Mazur G, Knakiewicz M, Frejlich E, Halon A (2013) High density of peritumoral lymphatic vessels measured by D2-40\/podoplanin and LYVE-1 expression in gastric cancer patients: an excellent prognostic indicator or a false friend? Gastric Cancer 16(4):513\u2013520","journal-title":"Gastric Cancer"},{"key":"1_CR205","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1746-1596-8-170","volume":"8","author":"VA Zorgetto","year":"2013","unstructured":"Zorgetto VA, Silveira GG, Oliveira-Costa JP, Soave DF, Soares FA, Ribeiro-Silva A (2013) The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas. Diagn Pathol 8:170","journal-title":"Diagn Pathol"},{"issue":"6","key":"1_CR206","first-page":"922","volume":"73","author":"JS Jong de","year":"1995","unstructured":"de Jong JS, van Diest PJ, Baak JP (1995) Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest 73(6):922\u2013926","journal-title":"Lab Invest"},{"issue":"1","key":"1_CR207","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/bjc.1997.333","volume":"76","author":"L Martin","year":"1997","unstructured":"Martin L, Holcombe C, Green B, Leinster SJ, Winstanley J (1997) Is a histological section representative of whole tumour vascularity in breast cancer? Br J Cancer 76(1):40\u201343","journal-title":"Br J Cancer"},{"issue":"4","key":"1_CR208","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.acthis.2013.12.003","volume":"116","author":"B Chen","year":"2014","unstructured":"Chen B, Fang WK, Wu ZY, Xu XE, Wu JY, Fu JH, Yao XD, Huang JH, Chen JX, Shen JH et al (2014) The prognostic implications of microvascular density and lymphatic vessel density in esophageal squamous cell carcinoma: comparative analysis between the traditional whole sections and the tissue microarray. Acta Histochem 116(4):646\u2013653","journal-title":"Acta Histochem"},{"issue":"7","key":"1_CR209","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4(7):844\u2013847","journal-title":"Nat Med"},{"issue":"7","key":"1_CR210","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nmeth772","volume":"2","author":"MJ LeBaron","year":"2005","unstructured":"LeBaron MJ, Crismon HR, Utama FE, Neilson LM, Sultan AS, Johnson KJ, Andersson EC, Rui H (2005) Ultrahigh density microarrays of solid samples. Nat Methods 2(7):511\u2013513","journal-title":"Nat Methods"},{"issue":"2","key":"1_CR211","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1200\/JCO.2007.13.7083","volume":"27","author":"D Generali","year":"2009","unstructured":"Generali D, Buffa FM, Berruti A, Brizzi MP, Campo L, Bonardi S, Bersiga A, Allevi G, Milani M, Aguggini S et al (2009) Phosphorylated ER\u03b1, HIF-1\u03b1, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer. J Clin Oncol 27(2):227\u2013234","journal-title":"J Clin Oncol"},{"issue":"3","key":"1_CR212","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1081\/BIP-200025657","volume":"14","author":"X Liu","year":"2004","unstructured":"Liu X, Minin V, Huang Y, Seligson DB, Horvath S (2004) Statistical methods for analyzing tissue microarray data. J Biopharm Stat 14(3):671\u2013685","journal-title":"J Biopharm Stat"},{"issue":"25","key":"1_CR213","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1016\/j.lfs.2003.05.006","volume":"73","author":"DH Zhang","year":"2003","unstructured":"Zhang DH, Salto-Tellez M, Chiu LL, Shen L, Koay ES (2003) Tissue microarray study for classification of breast tumors. Life Sci 73(25):3189\u20133199","journal-title":"Life Sci"},{"issue":"8","key":"1_CR214","first-page":"1141","volume":"29A","author":"E Protopapa","year":"1993","unstructured":"Protopapa E, Delides GS, Revesz L (1993) Vascular density and the response of breast carcinomas to mastectomy and adjuvant chemotherapy. Eur J Cancer 29A(8):1141\u20131145","journal-title":"Eur J Cancer"},{"key":"1_CR215","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1023\/A:1008280110558","volume":"8","author":"S Fox","year":"1997","unstructured":"Fox S, Engels K, Comley M, Whitehouse R, Turley H, Gatter K, Harris A (1997) Relationship of elevated tumour thymidine phosphorylase in node positive breast carcinomas to the effects of adjuvant CMF. Ann Oncol 8:271\u2013275","journal-title":"Ann Oncol"}],"container-title":["Methods in Molecular Biology","Angiogenesis Protocols"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3628-1_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T06:39:28Z","timestamp":1718519968000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3628-1_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493936267","9781493936281"],"references-count":215,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3628-1_1","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-3628-1","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"13 May 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}